Pfizer Inc. to Present New Clinical Data Highlighting Customized Treatment Approaches For Difficult-To-Treat Cancers

NEW YORK--(BUSINESS WIRE)--Pfizer will present new data highlighting the company’s commitment to a personalized approach to oncology clinical research, which includes the use of targeted agents in specific patient populations in several advanced and difficult-to-treat cancers. These data will be presented later this month at the 45th Annual American Society of Clinical Oncology (ASCO) annual meeting in Orlando from May 29 to June 2.
MORE ON THIS TOPIC